PGNY: Progyny Corp Price-to-Revenue Multiple

Brandmark of Progyny Corp (PGNY)

Progyny, Inc. (PGNY) maintains resilience against trade conflicts due to its focus on the US domestic market, as confirmed by the current price-to-sales ratio, which has settled at 2.10. This stability is bolstered by B2B contracts for employee reproductive health support, as well as a scalable cloud IT infrastructure that guarantees uninterrupted access to digital healthcare services for all clients.

PGNY Progyny Inc Price-to-Revenue Ratio (07/04/2022 - 11/17/2026)

Progyny, Inc. (PGNY) - metric breakdowns and financial figures

- current quotes and average value forecast:
General company analysis:PGNY, Progyny Inc
Mass-produced product of Progyny Corp

The P/S ratio reflects the market value of a single unit of revenue, allowing for an assessment of business overvaluation by comparing market capitalization with sales volume. By analyzing the P/S ratio chart, an investor can determine the monetization efficiency of Progyny, Inc. (PGNY) corporate subscriptions for reproductive health services and identify the risk of stock overvaluation should the growth rate of the client base slow down.

Competitors of Progyny, Inc.

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Ardent Health Partners (ARDT) - Price to Sales|Select Medical Inc. - P/S Multiple|Price to Sales Apollo Medical Holdings|MD: P/S Multiple|Market Cap to Revenue US Physical Therapy|Market Cap to Revenue PNTG|Organogenesis Holdings Inc. (ORGO) - Price-to-Revenue Coefficient|Market Cap to Revenue NUTX (Nutex Health Corp)|AUNA (Auna Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio sbc-holdings.com SBC|evolus.com - Price-to-Revenue Ratio|Community Health Systems, Inc. - P/S Multiple|SKIN: Price-to-Revenue Ratio|MDWD: P/S Multiple|BTMD: Market Cap to Sales Volume|Market Cap to Revenue JYNT|Price to Sales DocGo Inc. DCGO|PIII (P3 Health Partners, Inc.) - Price-to-Revenue Coefficient|GANX (Gain Therapeutics) - Market Capitalization-to-Revenue Ratio|P/S Multiple EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Price-to-Sales Ratio|CLGN - Price-to-Revenue Ratio|Price to Sales cuprina.com.sg|CCM: P/S Multiple|AMS: Market Cap to Sales Volume|MRM (MEDIROM Corp) - P/S Multiple|ALBT: Market Capitalization-to-Revenue Ratio|P/S Multiple DHAI|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume